COVID-19 Implications for I-O Patient Management

 View Only
last person joined: 7 months ago 

This discussion board is devoted to conversations directly relevant to clinical care. Example topics include:
• Trends in demographics
• Trends in clinical presentation
• Issues regarding diagnostic testing
• Patient management issues/insights
• Observations on emerging natural history/patterns in clinical complications
• Difficult cases
Thread Subject Replies Last Post
Shared Resources
   
8 06-11-2020 by SITC Education
Immune checkpoint inhibitors and COVID-19
   
0 04-28-2020 by Rajat Mohindra
Clinical trial endpoint preservation during Covid-19
   
1 04-15-2020 by Jarushka Naidoo
Original post by Jim Wise
EXPANDED ACCESS: oncology care AND ANTIVIRALS for COVID19
   
1 03-26-2020 by Ali Abdelnaser
Original post by Fernanda Arnaldez
Experience using remdesivir or other antivirals
   
1 03-26-2020 by Jon Wigginton
Original post by SITC Education
Big Pharma Response to COVID-19: Public Updates
   
0 03-23-2020 by Fernanda Arnaldez
Genentech Announces FDA Approval of Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia
   
0 03-23-2020 by Fernanda Arnaldez
COVID-19 in patients on a CD3-based bispecific
   
0 03-22-2020 by SITC Education
COVID-19 post CART cell therapy
   
0 03-22-2020 by SITC Education
COVID-19 in patients on checkpoint inhibitors
   
0 03-22-2020 by SITC Education
Showing 1 to 10 of 24 threads (24 total posts)